File Download
There are no files associated with this item.
Supplementary
-
Citations:
- Scopus: 0
- Appears in Collections:
Article: Intestinal transplantation: current status
Title | Intestinal transplantation: current status |
---|---|
Authors | |
Keywords | Article Catheter Infection Gastrointestinal Disease Graft Rejection Graft Survival Human Immunosuppressive Treatment Intestine Transplantation Liver Failure Liver Transplantation Lymphoproliferative Disease Major Clinical Study Opportunistic Infection Patient Care Survival Total Parenteral Nutrition |
Issue Date | 1999 |
Publisher | Elsevier (Singapore) Pte Ltd, Hong Kong Branch. The Journal's web site is located at http://www.elsevier.com/wps/find/journaldescription.cws_home/708511/description#description |
Citation | Asian Journal Of Surgery, 1999, v. 22 n. 2, p. 146-151 How to Cite? |
Abstract | Current Treatment Of Intestinal Failure Consists Of Long-Term Total Parenteral Nutrition, Which Is Associated With Major Complications Including Liver Failure And Catheter Problems. The Ultimate Solution Is Small Bowel Transplantation. After Overcoming Technical Difficulties, The Major Obstacle To Clinical Success Of Intestinal Transplantation Is Immunological. Intestinal Transplantation Is Characterized By An Aggressive Rejection Which Is Difficult To Control With Immunosuppression. The Introduction Of Tacrolimus For Use In Intestinal Transplantation In 1990 Has Resulted In Major Improvements In Short-Term Survival; But Long-Term Outcome Remains Unsatisfactory: There Is A High Incidence Of Rejection (Ineffective Immunosuppression), And Opportunistic Infection And Post-Transplant Lymphoproliferative Disease (Over-Immunosuppression). Up To 1997, 260 Patients Have Received 273 Transplants In 33 Centers, With Roughly Similar Numbers Of Isolated Small Bowel Transplantation And Combined Small Bowel And Liver Transplantation. Data From The Largest Series Reveal Patient Survival Of 72% At One Year, 58% At Two Years, And 33% At Five Years With A Graft Survival Of 61%, 43%, And 26%, Respectively. At Present, Intestinal Transplantation Can Be Considered As A Life-Saving Option For Patients With Intestinal Failure Who Cannot Tolerate Total Parenteral Nutrition. Major Advances In The Basic Understanding Of The Unique Immune Mechanisms Involved In Intestinal Transplantation And The Discovery Of New And Specific Immunosuppression Will Be Necessary To Allow The Therapeutic Procedure Of Transplantation To Realize Its Full Potential In The Clinical Management Of Intestinal Failure. |
Persistent Identifier | http://hdl.handle.net/10722/83408 |
ISSN | 2023 Impact Factor: 3.5 2023 SCImago Journal Rankings: 0.538 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tam, PKH | en_HK |
dc.contributor.author | Guo, WH | en_HK |
dc.date.accessioned | 2010-09-06T08:40:41Z | - |
dc.date.available | 2010-09-06T08:40:41Z | - |
dc.date.issued | 1999 | en_HK |
dc.identifier.citation | Asian Journal Of Surgery, 1999, v. 22 n. 2, p. 146-151 | en_US |
dc.identifier.issn | 1015-9584 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/83408 | - |
dc.description.abstract | Current Treatment Of Intestinal Failure Consists Of Long-Term Total Parenteral Nutrition, Which Is Associated With Major Complications Including Liver Failure And Catheter Problems. The Ultimate Solution Is Small Bowel Transplantation. After Overcoming Technical Difficulties, The Major Obstacle To Clinical Success Of Intestinal Transplantation Is Immunological. Intestinal Transplantation Is Characterized By An Aggressive Rejection Which Is Difficult To Control With Immunosuppression. The Introduction Of Tacrolimus For Use In Intestinal Transplantation In 1990 Has Resulted In Major Improvements In Short-Term Survival; But Long-Term Outcome Remains Unsatisfactory: There Is A High Incidence Of Rejection (Ineffective Immunosuppression), And Opportunistic Infection And Post-Transplant Lymphoproliferative Disease (Over-Immunosuppression). Up To 1997, 260 Patients Have Received 273 Transplants In 33 Centers, With Roughly Similar Numbers Of Isolated Small Bowel Transplantation And Combined Small Bowel And Liver Transplantation. Data From The Largest Series Reveal Patient Survival Of 72% At One Year, 58% At Two Years, And 33% At Five Years With A Graft Survival Of 61%, 43%, And 26%, Respectively. At Present, Intestinal Transplantation Can Be Considered As A Life-Saving Option For Patients With Intestinal Failure Who Cannot Tolerate Total Parenteral Nutrition. Major Advances In The Basic Understanding Of The Unique Immune Mechanisms Involved In Intestinal Transplantation And The Discovery Of New And Specific Immunosuppression Will Be Necessary To Allow The Therapeutic Procedure Of Transplantation To Realize Its Full Potential In The Clinical Management Of Intestinal Failure. | en_US |
dc.language | eng | en_HK |
dc.publisher | Elsevier (Singapore) Pte Ltd, Hong Kong Branch. The Journal's web site is located at http://www.elsevier.com/wps/find/journaldescription.cws_home/708511/description#description | en_US |
dc.relation.ispartof | Asian Journal of Surgery | en_HK |
dc.subject | Article | en_US |
dc.subject | Catheter Infection | en_US |
dc.subject | Gastrointestinal Disease | en_US |
dc.subject | Graft Rejection | en_US |
dc.subject | Graft Survival | en_US |
dc.subject | Human | en_US |
dc.subject | Immunosuppressive Treatment | en_US |
dc.subject | Intestine Transplantation | en_US |
dc.subject | Liver Failure | en_US |
dc.subject | Liver Transplantation | en_US |
dc.subject | Lymphoproliferative Disease | en_US |
dc.subject | Major Clinical Study | en_US |
dc.subject | Opportunistic Infection | en_US |
dc.subject | Patient Care | en_US |
dc.subject | Survival | en_US |
dc.subject | Total Parenteral Nutrition | en_US |
dc.title | Intestinal transplantation: current status | en_HK |
dc.type | Article | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1015-9584&volume=22&spage=146&epage=151&date=1999&atitle=Intestinal+transplantation:+current+status | en_HK |
dc.identifier.email | Tam, PKH: paultam@hkucc.hku.hk | en_HK |
dc.identifier.authority | Tam, PKH=rp00060 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.scopus | eid_2-s2.0-0033048208 | en_US |
dc.identifier.hkuros | 40660 | en_HK |
dc.identifier.volume | 22 | en_US |
dc.identifier.issue | 2 | en_US |
dc.identifier.spage | 146 | en_US |
dc.identifier.epage | 151 | en_US |
dc.identifier.issnl | 1015-9584 | - |